A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Baylor College of Medicine
University of Calgary
Institut Claudius Regaud
Gilead Sciences
Otsuka Pharmaceutical Co., Ltd.
H. Lee Moffitt Cancer Center and Research Institute
Gustave Roussy, Cancer Campus, Grand Paris
Shanghai Pharmaceuticals Holding Co., Ltd
Centre Oscar Lambret
National Institutes of Health Clinical Center (CC)
Janssen Research & Development, LLC
University of Illinois at Chicago
Beijing University of Chinese Medicine
City of Hope Medical Center
The Lymphoma Academic Research Organisation
Wake Forest University Health Sciences
Celgene
Allogene Therapeutics
Wake Forest University Health Sciences
Case Comprehensive Cancer Center
CEBIOTEX
Children's Hospital Medical Center, Cincinnati
Latin American Cooperative Oncology Group
Institute of Hematology & Blood Diseases Hospital, China
Pfizer
Baylor College of Medicine
University of California, San Diego
Prelude Therapeutics
Newave Pharmaceutical Inc